|
|
||||||||
J Thorac Cardiovasc Surg 2001;122:482-490
© 2001 The American Association for Thoracic Surgery
Evolving Technology (ET) |
From the Departments of Cardiology and Thoracic and Cardiovascular Surgery,a Kaufman Center for Heart Failure, and the Department of Biomedical Engineering,b Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio; and Myocor, Inc,c Maple Grove, Minn.
This study was funded by Myocor, Inc.
Received for publication June 15, 2000. Revisions requested Dec 11, 2000; revisions received Jan 17, 2001. Accepted for publication Feb 20, 2001. Address for reprints: Patrick M. McCarthy, MD, Department of Thoracic & Cardiovascular Surgery, Cleveland Clinic Foundation, 9500 Euclid Ave, F25, Cleveland, OH 44195 (E-mail: mccartp{at}ccf.org).
Abstract
Objective: We tested a unique new device, the Myosplint device (Myocor, Inc, Maple Grove, Minn), which is designed to change left ventricular shape, reduce left ventricular wall stress, and improve left ventricular systolic function.
Methods: Heart failure was induced in 15 dogs over 27 days by rapid pacing (230 beats/min). Seven animals underwent sham surgery, and 8 animals received 3 transventricular Myosplint devices each. Myosplint devices were tightened to create a symmetric bilobular left ventricular shape and were adjusted to produce a calculated 20% reduction in wall stress. Hemodynamic, 2-dimensional, and 3-dimensional echocardiographic studies were recorded at baseline, immediately after Myosplint placement (acute change), and at 1 month after both groups had a reduced rate (190 beats/min) of pacing designed to maintain heart failure.
Results: The Myosplint group had significant sustained improvements in left ventricular ejection fraction from baseline, to the acute change, to 1 month (19% ± 5%; 36% ± 8%; 39% ± 13%) and reductions of left ventricular end-systolic volumes (73 ± 9 mL; 34 ± 5 mL; 42 ± 12 mL) and end-systolic wall stress by 39% (341 ± 68 103 dynes · cm 2 to 206 ± 28 103 dynes · cm2) acutely and 31% (372 ± 83 103 dynes · cm2 to 250 ± 40 103 dynes · cm2) at 1 month. There were no significant changes in mitral regurgitation.
Conclusion: Application of a Myosplint device to a dilated impaired left ventricle resulted in reduced wall stress and improved left ventricular systolic function that was sustained at 1 month. Device-based shape change is a promising new opportunity to treat patients with dilated cardiomyopathy.
Related Article
J. Thorac. Cardiovasc. Surg. 2001 122: 421-423.
This article has been cited by other articles:
![]() |
A. Olsson, F. Bredin, and A. Franco-Cereceda Echocardiographic findings using tissue velocity imaging following passive containment surgery with the Acorn CorCapTM cardiac support device Eur. J. Cardiothorac. Surg., September 1, 2005; 28(3): 448 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Tibayan, F. Rodriguez, F. Langer, D. Liang, G. T. Daughters, N. B. Ingels Jr, and D. C. Miller Undersized Mitral Annuloplasty Alters Left Ventricular Shape During Acute Ischemic Mitral Regurgitation Circulation, September 14, 2004; 110(11_suppl_1): II-98 - II-102. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inoue, P. M. McCarthy, Z. B. Popovic, K. Doi, S. Schenk, H. Nemeh, Y. Ootaki, M. W. Kopcak Jr, R. Dessoffy, J. D. Thomas, et al. The Coapsys device to treat functional mitral regurgitation: In vivo long-term canine study J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1068 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Sabbah, V. G. Sharov, R. C. Gupta, S. Mishra, S. Rastogi, A. I. Undrovinas, P. A. Chaudhry, A. Todor, T. Mishima, E. J. Tanhehco, et al. Reversal of Chronic Molecular and Cellular Abnormalities Due to Heart Failure by Passive Mechanical Ventricular Containment Circ. Res., November 28, 2003; 93(11): 1095 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Guccione, A. Salahieh, S. M. Moonly, J. Kortsmit, A. W. Wallace, and M. B. Ratcliffe Myosplint decreases wall stress without depressing function in the failing heart: a finite element model study Ann. Thorac. Surg., October 1, 2003; 76(4): 1171 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.P. Lunkenheimer, K. Redmann, J.C. Florek, H.H. Scheld, A. Hoffmeier, C.W. Cryer, R.V. Batista, J.J. Stanton, J.D. F. Filho, and R.H. Anderson Surgical reduction of ventricular radius by aspirated plication of the myocardial wall: an experimental study J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 592 - 596. [Full Text] [PDF] |
||||
![]() |
K.-l. He, J. Shimizu, G.-h. Yi, A. Gu, M. A. Kashem, D. L. Crabbe, S. Popilskis, E. X. Wu, W. P. Santamore, D. Melvin, et al. Left ventricular systolic performance in failing heart improved acutely by left ventricular reshaping J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 56 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Sabbah The cardiac support device and the Myosplint: treating heart failure by targeting left ventricular size and shape Ann. Thorac. Surg., June 1, 2003; 75(90060): S13 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koyama, K. Nishimura, Y. Soga, O. Unimonh, K. Ueyama, and M. Komeda Importance of preserving the apex and plication of the base in left ventricular volume reduction surgery J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 669 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Burkhoff New heart failure therapy: The shape of things to come? J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(90030): S50 - 52. [Full Text] [PDF] |
||||
![]() |
S. Morita, Y. Ochiai, Y. Tanoue, M. Hisahara, M. Masuda, and H. Yasui Acute volume reduction with aortic valve replacement immediately improves ventricular mechanics in patients with aortic regurgitation J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 283 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kashem, S. Hassan, D. L. Crabbe, D. B. Melvin, and W. P. Santamore Left ventricular reshaping: Effects on the pressure-volume relationship J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 391 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Saavedra, R. S. Tunin, N. Paolocci, T. Mishima, G. Suzuki, C. W. Emala, P. A. Chaudhry, P. Anagnostopoulos, R. C. Gupta, H. N. Sabbah, et al. Reverse remodeling and enhancedadrenergic reserve from passive externalsupport in experimental dilated heart failure J. Am. Coll. Cardiol., June 19, 2002; 39(12): 2069 - 2076. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takagaki, P. M. McCarthy, T. Tabata, R. Dessoffy, L. A. Cardon, J. Connor, Y. Ochiai, J. D. Thomas, G. S. Francis, J. B. Young, et al. Induction and maintenance of an experimental model of severe cardiomyopathy with a novel protocol of rapid ventricular pacing J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 544 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Burkhoff New heart failure therapy: The shape of things to come? J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 421 - 423. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |